✦ LIBER ✦

A phase I study of dose-dense “alternating doublets” chemotherapy with filgrastim (rhG-CSF) support in advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Watson, S.M; Gordon, G.S; Mauer, A.M; Rudin, C.R; Hoffman, P.C; Krauss, S.A; Szeto, L; Golomb, H.M; Vokes, E.E

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of paclitaxel, ifosfamide

✍ Mauer, A.M; Ansari, R.H; Hoffman, P.C; Gabrys, T.G 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 211 KB

Phase I/II study of cisplatin, ifosfamid

✍ Akihisa Fujita; Hirotsugu Takabatake; Shigeru Tagaki; Kyuhichiro Sekine 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 80 KB

Biweekly docetaxel-irinotecan with filgr

✍ Giuseppe Frasci; Pasquale Comella; Renato Thomas; Maurizio Di Bonito; Liliana La 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 811 KB

Biweekly docetaxel-irinotecan with filgr

✍ Giuseppe Frasci; Pasquale Comella; Renato Thomas; Maurizio Bonito; Liliana Lapen 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 197 KB

A Phase I study of Nedaplatin (CDGP) and

✍ Saito, J; Nakai, Y; Koinumaru, S; Matsuda, T; Saijo, Y; Nukiwa, T 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

A phase I dose escalation study of multi

✍ Takahashi, M; Yoshizawa, H; Tanaka, H; Tanaka, J; Kagamu, H; Ito, K; Shimbo, T; 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 83 KB